Markets:

Overview

News

Currencies

International

Treasuries

Helmerich & Payne (NY:HP)

43.85 -0.71 (-1.59%)

Streaming Delayed Price Updated: 10:52 AM EDT, Sep 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Helmerich & Payne

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Buy/Sell: Wall Street's Top 10 Stock Calls This Week - Saturday, April 22 ↗

April 22, 2023

What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street’s best analysts during the week of April 17-21.

Via Talk Markets

Don't Be Fooled By The Price Of Oil ↗

April 22, 2023

After spending the first four days of the week dropping, the United States Oil ETF USO saw a bump on Friday. Traders and investors alike were losing their minds. This won't last. It can't last.

Via Talk Markets

Analyst Expectations for Helmerich & Payne's Future ↗

April 18, 2023

Via Benzinga

NVIDIA To Rally Over 31%? Here Are 10 Other Analyst Forecasts For Tuesday ↗

April 18, 2023

Wells Fargo cut the price target for Marathon Oil Corporation (NYSE: MRO) from $40 to $38. Wells Fargo analyst Roger Read maintained an Overweight rating. Marathon Oil shares fell 0.3% to $24.72 in...

Via Benzinga

Helmerich & Payne, Inc. Announces Fiscal Second Quarter 2023 Conference Call and Webcast

April 05, 2023

From Helmerich & Payne, Inc.

Via Business Wire

The Latest Analyst Ratings for Helmerich & Payne ↗

March 27, 2023

Via Benzinga

Earnings Preview For Helmerich & Payne ↗

January 27, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2023 ↗

April 18, 2023

Via Benzinga

Helmerich & Payne, Inc. To Participate in Conferences in March 2023

March 16, 2023

From Helmerich & Payne, Inc.

Via Business Wire

The Latest Analyst Ratings for Helmerich & Payne ↗

January 19, 2023

Via Benzinga

Helmerich & Payne Stock, A Lot More Upside Than Meets the Eye

March 06, 2023

Massive investor benefits coming to HP, along with a revised prediction for higher oil prices pushing further alpha in the stock's target price.

Via MarketBeat

Topics Economy

AMD Anticipates Long Term Market Share Gains In Client Computing And Data Center: Analyst ↗

February 14, 2023

Benchmark analyst Cody Acree maintained Advanced Micro Devices Inc (NASDAQ: AMD) with a Buy and

Via Benzinga

Market Rally Powers Higher On Tame Fed, Meta Earnings; Apple, Google, Amazon In Focus: Weekly Review ↗

February 03, 2023

The major indexes continued to run despite mixed-to-weak earnings.

Via Investor's Business Daily

Helmerich & Payne, Inc. Announces Fiscal First Quarter Results

January 30, 2023

From Helmerich & Payne, Inc.

Via Business Wire

Earnings Scheduled For January 30, 2023 ↗

January 30, 2023

Companies Reporting Before The Bell • Franklin Resources (NYSE:BEN) is expected to report quarterly earnings at $0.54 per share on revenue of $1.86 billion.

Via Benzinga

Whirlpool, Ryanair And 3 Stocks To Watch Heading Into Monday ↗

January 30, 2023

With US stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Fear & Greed Index Remains In 'Greed' Zone As Nasdaq Record Gains For Fourth Straight Week ↗

January 30, 2023

The CNN Money Fear and Greed index remained in the "Greed" zone on Friday after stocks closed mostly higher on Friday. The Nasdaq index gained around 4.3% last week, notching gains for the fourth...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2023 ↗

January 19, 2023

Via Benzinga

Helmerich & Payne, Inc. Announces Fiscal First Quarter 2023 Conference Call and Webcast

January 09, 2023

From Helmerich & Payne, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For January 9, 2023 ↗

January 09, 2023

Via Benzinga

Dell Eyes Reducing Dependence On China - India, Latin America Likely To Be Beneficiaries, Analysts Say ↗

January 05, 2023

Via Benzinga

Bulls In A Bear Market: These 10 Stocks Clocked Gains In Excess Of 100% In 2022 ↗

December 31, 2022

2022 would go down as one of the worst years for the financial markets. The sell-off has been all-pervasive, with stocks, bonds and cryptos all selling off indiscriminately. Even as high-fliers like...

Via Benzinga

Helmerich & Payne, Inc. To Participate in Conferences in January 2023

December 30, 2022

From Helmerich & Payne, Inc.

Via Business Wire

Will Energy Stocks Have Another Strong Year in 2023? ↗

December 20, 2022

Energy was one of the few areas of the stock market that held up well in 2022, but what about next year?

Via The Motley Fool

Helmerich & Payne, Inc. Announces Release of its 2022 Sustainability Report

December 13, 2022

From Helmerich & Payne, Inc.

Via Business Wire

Here Are the 5 Big Moves Warren Buffett Made in 2022 ↗

December 12, 2022

Warren Buffett made five big buys this year, showing an affinity for energy and tech.

Via The Motley Fool

CBOE's Weekly Market Recap: Nov.14-18 – Biogen's Alzheimer's Drug Captures Investors' Attention ↗

November 23, 2022

The market has experienced some relief from bearish price action in November, continuing October’s push to usher the SPDR S&P 500 ETF (NYSEARCA: SPY) toward $400.

Via Benzinga

Carvana, Crocs And Other Big Losers From Monday ↗

November 22, 2022

U.S. stocks closed lower on Monday, with the Nasdaq dropping more than 100 points. Here is the list of some big stocks recording losses in the previous session.

Via Benzinga

Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday ↗

November 22, 2022

Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.

Via Benzinga

Why TuanChe Shares Are Trading Lower By 76%? Here Are 48 Stocks Moving In Monday's Mid-Day Session ↗

November 21, 2022

Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares jumped 104% to $35.50 after Merck announced it would acquire the company for $36 per share in cash.

Via Benzinga

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.